Cellectar Biosciences, Inc. Operating Leases, Rent Expense
Cellectar Biosciences, Inc. (CLRB) reported Operating Leases, Rent Expense of $29.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-26
- Cellectar Biosciences, Inc. operating leases, rent expense for fiscal 2018 was $29.00K, a 77.69% decline from fiscal 2017.
- Cellectar Biosciences, Inc. operating leases, rent expense for fiscal 2017 was $130.00K, a 0.76% decline from fiscal 2016.
- Cellectar Biosciences, Inc. operating leases, rent expense for fiscal 2016 was $131.00K, a 7.75% decline from fiscal 2015.
- Cellectar Biosciences, Inc. operating leases, rent expense for fiscal 2015 was $142.00K, a 21.11% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense 0 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 122 month | Operating Leases, Rent Expense 134 month |
|---|---|---|---|---|
| 2018-12-31 | $29.00K 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $130.00K 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $131.00K 10-K · filed 2018-03-21 | |||
| 2015-12-31 | $142.00K 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $180.00K 10-K/A · filed 2016-10-20 | |||
| 2013-12-31 | $229.00K 10-K · filed 2015-05-20 | $1.60M 10-K · filed 2014-03-19 | ||
| 2012-12-31 | $227.00K 10-K · filed 2014-03-19 | $1.37M 10-K · filed 2013-03-28 | ||
| 2011-12-31 | $197.00K 10-K · filed 2013-03-28 | |||
| 2007-12-31 | $8.05K 10-K · filed 2015-05-20 | |||
| 2007-09-05 | $8.05K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |